Note from June 29, 2020
Although we do not yet know how long the social distancing related to the Covid-19 pandemic will last, and regardless of the changes that had to be made in the evaluation of the June 2020 session in relation to what is provided for in this learning unit description, new learnig unit evaluation methods may still be adopted by the teachers; details of these methods have been - or will be - communicated to the students by the teachers, as soon as possible.
Although we do not yet know how long the social distancing related to the Covid-19 pandemic will last, and regardless of the changes that had to be made in the evaluation of the June 2020 session in relation to what is provided for in this learning unit description, new learnig unit evaluation methods may still be adopted by the teachers; details of these methods have been - or will be - communicated to the students by the teachers, as soon as possible.
3 credits
30.0 h + 15.0 h
Q2
Teacher(s)
Bindels Laure; Frédérick Raphaël; Henrard Séverine; Leclercq Joëlle; Van Bambeke Françoise (coordinator);
Language
French
Prerequisites
basic knowledge of pharmacology
Main themes
- Definition of drug targets in the context of physiopathology and in a economical and societal perspective
- Discovery methods
- Steps of preclinical and clinical development
-Registration and refund by social security
-Pharmacovigilance
- Discovery methods
- Steps of preclinical and clinical development
-Registration and refund by social security
-Pharmacovigilance
Aims
At the end of this learning unit, the student is able to : | |
| 1 |
Analysis and understanding of the successive steps leading to the discovery, the preclinical and clinical development, and the commercialization of drugs. Knowledge of the process for integrating it in professional activities |
The contribution of this Teaching Unit to the development and command of the skills and learning outcomes of the programme(s) can be accessed at the end of this sheet, in the section entitled “Programmes/courses offering this Teaching Unit”.
Content
2h sessions centered on one specific aspect, with description and analysis of the considered aspects and examples taken from drug development history.
Evaluation methods
- Written examination with open questions (discussion starting from practical examples)
- Individual work, aiming at proposing the development plan of a fictive drug
- Individual work, aiming at proposing the development plan of a fictive drug
Faculty or entity
FARM
